This user has not added any information to their profile yet.
Postdoctoral Research Officer
Infection, Immunity and Global Health
Murdoch Children's Research Institute
VIIN Emerging Leaders Committee
Food allergy, oral immunotherapy, systems immunology
0000-0001-9973-9742
Sarah Ashley
- Correlation and Agreement Between Parent-Report and Self-Report Food Allergy Quality of Life Questionnaires After Oral Immunotherapy.
- Three-Year Post-Treatment Outcomes Following Cessation of Peanut Oral Immunotherapy: Comparisons by Clinical Allergy Status and Treatment Group.
- Understanding the Variability of Peanut-Oral Immunotherapy Responses by Multi-Omics Profiling of Immune Cells.
- Probiotic oral immunotherapy for egg and milk allergy induces sustained unresponsiveness.
- Sex assigned at birth may modify health-related quality of life in children treated with peanut oral immunotherapy.
- Allergen-Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1-10 Years.
- Two-year post-treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy-003 Long-Term (PPOIT-003LT) study.
- Transcriptomic changes associated with oral immunotherapy for food allergy.
- Remission of peanut allergy is associated with rewiring of allergen-driven T helper 2-related gene networks.
- Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement.
- Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy (PPOIT) in children with peanut allergy.
- The skin barrier function gene SPINK5 is associated with challenge-proven IgE-mediated food allergy in infants.
- Genetic variation at the Th2 immune gene IL13 is associated with IgE-mediated paediatric food allergy.
